The Inner Life of Sea Squirts
Innovative Study Finds Way to "Bio-Synthesize" an Anti-Cancer Compound
5:00 p.m. EST May 9, 2005
The University of Utah and The Institute for Genomic Research -- In a project that could have far-reaching implications for natural-product drug development, scientists have shown how a microbe that lives inside sea squirts could be used to biosynthesize a chemical compound that may help fight cancer.
The photosynthetic microbe, Prochloron didemni, lives as an endosymbiont inside the sea squirt Lissoclinum patella. So far, scientists have not been able to culture the microbe anywhere else.
Ground-up extracts of that sea squirt have been shown to contain patellamides, small peptides that appear useful in treating some cancers. Until this study, scientists had suspected — but had not proven — that Prochloron microbes produce patellamides.
The research paper, published online this week in the Proceedings of the National Academy of Sciences (PNAS), demonstrates that Prochloron didemni produces two patellamide compounds (A and C) and pinpoints the gene pathways that are used in that chemical biosynthesis.
"Coral reefs and other ocean environments are like rainforests — full of natural chemicals to potentially treat human disease," says Eric W. Schmidt, Ph.D., assistant professor of medicinal chemistry at the University of Utah's College of Pharmacy. "Unfortunately, it's difficult to supply pharmaceuticals from these delicate environments. We have solved this by finding specific genes for the synthesis of chemicals using laboratory bacteria."
Schmidt had isolated and prepared the DNA of the microbe samples collected from sea squirts in the seabed near the Republic of Palau in Micronesia. Jacques Ravel, Ph.D., and other scientists at The Institute for Genomic Research (TIGR) in Rockville, MD, then sequenced the Prochloron genome. Working with Schmidt, they found the chemical pathways in the microbe's gene sequence that are responsible for producing patellamide A and C.
Ravel, who led TIGR's role in the project, says: "For the first time, we have demonstrated the bacterial origin of a natural product from tunicates, an important source of marine drug candidates." He added that the study "demonstrates how genomics can assist natural products chemistry and work towards sustainable production of important marine drug candidates from microbes. This process can speed up the time it takes for a drug to go from lead compound to actual drugs."
By proving that the patellamide compounds are made by the microbes inside sea squirts, scientists say, the study shows it would be possible to produce sufficient quantities of patellamides through biosynthesis without having to destroy a large numbers of sea squirts in the process. The study was funded as part of a National Science Foundation (NSF) grant in the Emerging Frontiers program (Microbial Genome Sequencing).
Because patellamides are small cyclic peptides (consisting of eight amino acids), scientists had at first thought that — as in the case of many other small cyclic peptides — the biosynthetic mechanism involved a "non-ribosomal peptide synthetase," a large multimodular enzyme that incorporates amino acids residue into a peptide.
When scientists did not find such a chemical system related to patellamides in the microbe's draft genome sequence, they examined alternative biosynthetic mechanisms. Because it is a peptide, a ribosomal mechanism was an obvious possibility.
In a collaboration with Schmidt, TIGR scientists looked for every combination of eight amino acids constituting the cyclic patellamides in the draft genome. Ravel's group found the sequence for Patellamide A, and — after further examination — Schmidt's group found the Patellamide C sequence adjacent to the patellamide A sequence in the same pre-peptides. After the gene cluster was annotated, Schmidt used the TIGR information to develop the likely mechanism for the biosynthesis of the patellamides and he demonstrated how the biosynthesis could be accomplished.
The Prochloron genome project — which also involves collaborator Margo Haygood at the Scripps Institution of Oceanography at the University of California in San Diego — is still under way, with scientists exploring more aspects of the microbe's DNA sequence.
TIGR's Jonathan Eisen, an evolutionary biologist, says the PNAS study also helps explain how a specific microbe contributes to the biology of its host organism: "This study is particularly important since it helps reveal how a bacterial symbiont plays a role in the biology of a tunicate, which as a representative of the chordates, is not so far away from humans in the tree of life."
Eisen says the study "shows yet another way that microorganisms contribute to the biology of animals. Most animals, including humans, simply cannot survive without the functions and activities provided to them by mutualistic microorganisms that live either inside or in association with them."
Jacques Ravel, Ph.D., (301) 795-7884 jravel@tigr.org
The University of Utah, in Salt Lake City, is a major teaching and research university. The University's health sciences programs in medicine, pharmacy, human genetics, nursing, and health are nationally recognized. Last year, the University received more than $300 million in research funds from sources outside of Utah.
University of Utah:
Eric W. Schmidt, Ph.D., (801) 585-5234 ews1@utah.edu
Phil Sahm, Office of Public Affairs, (801) 581-2517 Phil.Sahm@hsc.utah.edu